$MITK
MITEK SYSTEMS INC

2013 Q2 Form 10-Q Financial Statement

#000119312513321455 Filed on August 06, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $3.882M $3.162M
YoY Change 22.78% 7.18%
Cost Of Revenue $469.4K $360.0K
YoY Change 30.4% -18.18%
Gross Profit $3.413M $2.800M
YoY Change 21.88% 11.11%
Gross Profit Margin 87.91% 88.56%
Selling, General & Admin $3.494M $2.705M
YoY Change 29.19% 86.53%
% of Gross Profit 102.39% 96.6%
Research & Development $1.976M $2.117M
YoY Change -6.67% 186.1%
% of Gross Profit 57.9% 75.61%
Depreciation & Amortization $90.00K $70.00K
YoY Change 28.57% 40.0%
% of Gross Profit 2.64% 2.5%
Operating Expenses $5.470M $4.822M
YoY Change 13.45% 120.18%
Operating Profit -$2.058M -$2.019M
YoY Change 1.89% -711.94%
Interest Expense $10.00K $10.00K
YoY Change 0.0%
% of Operating Profit
Other Income/Expense, Net $5.592K $10.51K
YoY Change -46.81%
Pretax Income -$2.052M -$2.009M
YoY Change 2.15% -708.75%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.052M -$2.009M
YoY Change 2.15% -708.75%
Net Earnings / Revenue -52.86% -63.54%
Basic Earnings Per Share -$0.08 -$0.08
Diluted Earnings Per Share -$0.08 -$0.08
COMMON SHARES
Basic Shares Outstanding 27.11M 25.61M shares
Diluted Shares Outstanding 27.11M 25.61M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $29.50M $15.00M
YoY Change 96.67% -8.54%
Cash & Equivalents $22.95M $6.193M
Short-Term Investments $6.500M $8.900M
Other Short-Term Assets $608.1K $500.0K
YoY Change 21.63% 150.0%
Inventory
Prepaid Expenses
Receivables $572.4K $3.200M
Other Receivables $0.00 $0.00
Total Short-Term Assets $30.64M $18.80M
YoY Change 62.99% -5.05%
LONG-TERM ASSETS
Property, Plant & Equipment $1.560M $400.0K
YoY Change 290.04% 300.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $400.0K
YoY Change -100.0%
Other Assets $42.05K $0.00
YoY Change
Total Long-Term Assets $1.602M $800.0K
YoY Change 100.28% 166.67%
TOTAL ASSETS
Total Short-Term Assets $30.64M $18.80M
Total Long-Term Assets $1.602M $800.0K
Total Assets $32.24M $19.60M
YoY Change 64.51% -2.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.337M $1.300M
YoY Change 79.76% 160.0%
Accrued Expenses $1.200M $700.0K
YoY Change 71.43% 40.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.441M $3.700M
YoY Change 74.09% 68.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.379M $100.0K
YoY Change 1279.08%
Total Long-Term Liabilities $1.379M $100.0K
YoY Change 1279.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.441M $3.700M
Total Long-Term Liabilities $1.379M $100.0K
Total Liabilities $7.821M $3.800M
YoY Change 105.8% 72.73%
SHAREHOLDERS EQUITY
Retained Earnings -$29.26M
YoY Change
Common Stock $29.92K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.42M $15.80M
YoY Change
Total Liabilities & Shareholders Equity $32.24M $19.60M
YoY Change 64.51% -2.49%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$2.052M -$2.009M
YoY Change 2.15% -708.75%
Depreciation, Depletion And Amortization $90.00K $70.00K
YoY Change 28.57% 40.0%
Cash From Operating Activities $840.0K -$1.870M
YoY Change -144.92% -913.04%
INVESTING ACTIVITIES
Capital Expenditures -$530.0K -$120.0K
YoY Change 341.67% 500.0%
Acquisitions
YoY Change
Other Investing Activities -$1.240M $1.880M
YoY Change -165.96% -178.01%
Cash From Investing Activities -$1.770M $1.760M
YoY Change -200.57% -172.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.88M 90.00K
YoY Change 15322.22% -99.35%
NET CHANGE
Cash From Operating Activities 840.0K -1.870M
Cash From Investing Activities -1.770M 1.760M
Cash From Financing Activities 13.88M 90.00K
Net Change In Cash 12.95M -20.00K
YoY Change -64850.0% -100.17%
FREE CASH FLOW
Cash From Operating Activities $840.0K -$1.870M
Capital Expenditures -$530.0K -$120.0K
Free Cash Flow $1.370M -$1.750M
YoY Change -178.29% -800.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
400000
CY2013Q1 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
0
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30348944 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3600865 shares
CY2012Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
3.42
CY2012Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6193014
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
6732813
CY2013Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
4.01
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
1328679 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2012Q2 mitk Entity Wide Major Customers Accounts Receivable Net
EntityWideMajorCustomersAccountsReceivableNet
2099200
CY2012Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
22523 sqft
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29916403 shares
CY2013Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
2670743 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29916403 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1342064 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.01
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2670743 shares
CY2013Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
3.04
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2013Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
179865
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
53661424
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2336825
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6441455
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3561
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1238682
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1379081
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
24423412
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
3561
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
16000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29264367
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2686083
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
29916
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32243948
CY2013Q2 us-gaap Liabilities
Liabilities
7820536
CY2013Q2 us-gaap Assets Current
AssetsCurrent
30641743
CY2013Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
6519143
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42049
CY2013Q2 us-gaap Assets
Assets
32243948
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22945632
CY2013Q2 us-gaap Short Term Investments
ShortTermInvestments
6515582
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
572382
CY2013Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
6515582
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7282518
CY2013Q2 us-gaap Other Assets Current
OtherAssetsCurrent
608147
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
7256141
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1560156
CY2013Q2 mitk Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Under Prior Plans Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingUnderPriorPlansNumber
1612222 shares
CY2013Q2 mitk Number Of Financial Institutions That Deployed Software
NumberOfFinancialInstitutionsThatDeployedSoftware
559 Companies
CY2013Q2 mitk Leasehold Space Amended
LeaseholdSpaceAmended
24012 sqft
CY2013Q2 mitk Entity Wide Major Customers Accounts Receivable Net
EntityWideMajorCustomersAccountsReceivableNet
81142
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3512286 shares
CY2013Q2 mitk Deferred Tax Valuation Allowance Net Of Assets Percentage
DeferredTaxValuationAllowanceNetOfAssetsPercentage
1.00 pure
CY2013Q2 mitk Number Of Financial Institutions That Signed Agreement
NumberOfFinancialInstitutionsThatSignedAgreement
1059 Institution
CY2013Q2 mitk Number Of Domestic Retail Banks And Payment Processing Companies
NumberOfDomesticRetailBanksAndPaymentProcessingCompanies
33 Companies
CY2013Q2 mitk Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
4317
CY2013Q2 mitk Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
756
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5655716
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25995216 shares
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25995216 shares
CY2012Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.39
CY2012Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
31656
CY2012Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
36990691
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
711950
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3102656
CY2012Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-616
CY2012Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
726965
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
63586
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
13556679
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
17773
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23459391
CY2012Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1632085
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
25995
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16722921
CY2012Q3 us-gaap Liabilities
Liabilities
3166242
CY2012Q3 us-gaap Long Term Investments
LongTermInvestments
2085690
CY2012Q3 us-gaap Assets Current
AssetsCurrent
14104103
CY2012Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
7905843
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42049
CY2012Q3 us-gaap Assets
Assets
16722921
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6702090
CY2012Q3 us-gaap Short Term Investments
ShortTermInvestments
5819537
CY2012Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1097311
CY2012Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
7905227
CY2012Q3 us-gaap Other Assets Current
OtherAssetsCurrent
485165
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
491079
CY2012Q3 mitk Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
4643
CY2012Q3 mitk Availableforsale Securities Gross Unrealized Gain Loss Accumulated In Aoci
AvailableforsaleSecuritiesGrossUnrealizedGainLossAccumulatedInAoci
616
CY2012Q3 mitk Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
4027
dei Trading Symbol
TradingSymbol
MITK
dei Entity Registrant Name
EntityRegistrantName
MITEK SYSTEMS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0000807863
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P7Y4M24D
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26534357 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.69 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.25
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y18D
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2013-01-31
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M24D
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26534357 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.96
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1623815
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.90
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
489063 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26534357 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1103582 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
227024 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3348664 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 4%"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Use of Estimates</i></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses and the related disclosure of contingent assets and liabilities. On an ongoing basis, management reviews its estimates based upon currently available information. Actual future results could differ materially from those estimates.</font></p> </div>
us-gaap Revenues
Revenues
10415954
us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
2976150
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5807921
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5804176
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18927
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
129046
us-gaap Licenses Revenue
LicensesRevenue
7439804
us-gaap Income Taxes Paid
IncomeTaxesPaid
800
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
171990
us-gaap Operating Income Loss
OperatingIncomeLoss
-5823103
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
4059036
us-gaap Interest Paid
InterestPaid
6231
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1122549
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-526702
us-gaap Net Income Loss
NetIncomeLoss
-5804976
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
12524
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1278334
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2945
us-gaap Costs And Expenses
CostsAndExpenses
16239057
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
110119
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
511717
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5849052
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
154010
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14616363
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1476228
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1053998
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3832374
us-gaap Share Based Compensation
ShareBasedCompensation
2045767
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1773
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
16243542
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4143346
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1624875
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13877447
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3364
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5020127
us-gaap Other Cost Of Services
OtherCostOfServices
639617
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
751440
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
209257
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2045767
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5340734
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
0
us-gaap License Costs
LicenseCosts
586915
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800
mitk Commencement Of Lease Amendment Period
CommencementOfLeaseAmendmentPeriod
2013-01-01
mitk Maturity Of Short Term Investments
MaturityOfShortTermInvestments
Less than one year
mitk Percentage Effect Of Lease Amendment Increase Or Decrease In Rent
PercentageEffectOfLeaseAmendmentIncreaseOrDecreaseInRent
0.03 pure
mitk Cashless Exercise Of Options And Warrants
CashlessExerciseOfOptionsAndWarrants
125
mitk Effect Of Lease Amendment Increase Or Decrease In Rent
EffectOfLeaseAmendmentIncreaseOrDecreaseInRent
471000
mitk Extension Of Lease Period
ExtensionOfLeasePeriod
2019-06-30
mitk Cashless Settlement Of Restricted Stock Units
CashlessSettlementOfRestrictedStockUnits
16
mitk Percentage Of Vendor Comprising Of Overall Purchases
PercentageOfVendorComprisingOfOverallPurchases
0.10 pure
mitk Maturity Of Long Term Investments
MaturityOfLongTermInvestments
Greater than one year
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24980253 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.90 pure
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y9M15D
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24980253 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1025614
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24980253 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y8M5D
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4071700 shares
us-gaap Revenues
Revenues
7872951
us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
2011560
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4820992
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
95388
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4829169
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26949
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
218919
us-gaap Licenses Revenue
LicensesRevenue
5861391
us-gaap Income Taxes Paid
IncomeTaxesPaid
800
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
219152
us-gaap Operating Income Loss
OperatingIncomeLoss
-4856118
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8174049
us-gaap Interest Paid
InterestPaid
8071
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
234517
us-gaap Net Income Loss
NetIncomeLoss
-4829969
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
10991
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
213299
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
8977
us-gaap Costs And Expenses
CostsAndExpenses
12729069
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
191970
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
219366
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4089315
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
199440
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
615255
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-47154
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
795903
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14028720
us-gaap Share Based Compensation
ShareBasedCompensation
1983870
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
702
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
537298
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2641569
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
920412
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
947657
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5026959
us-gaap Other Cost Of Services
OtherCostOfServices
543627
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
626246
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
185485
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1983870
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
9335005
us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
0
us-gaap License Costs
LicenseCosts
427599
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800
mitk Cashless Exercise Of Options And Warrants
CashlessExerciseOfOptionsAndWarrants
399
mitk Percentage Of Vendor Comprising Of Overall Purchases
PercentageOfVendorComprisingOfOverallPurchases
0.10 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M16D
CY2012 mitk Maturity Of Short Term Investments
MaturityOfShortTermInvestments
Less than one year
CY2012 mitk Maturity Of Long Term Investments
MaturityOfLongTermInvestments
Greater than one year
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25613698 shares
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2012Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
shares
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25613698 shares
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25613698 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4071700 shares
CY2012Q2 us-gaap Revenues
Revenues
3161729
CY2012Q2 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
697813
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2009959
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2008887
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10514
CY2012Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
72781
CY2012Q2 us-gaap Licenses Revenue
LicensesRevenue
2463916
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2019401
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-2008887
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1072
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
5181130
CY2012Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
62267
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1626133
CY2012Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1078603
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2117174
CY2012Q2 us-gaap Other Cost Of Services
OtherCostOfServices
188809
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
830986
CY2012Q2 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
0
CY2012Q2 us-gaap License Costs
LicenseCosts
170411
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27109787 shares
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2013Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27109787 shares
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27109787 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3348664 shares
CY2013Q2 us-gaap Revenues
Revenues
3882027
CY2013Q2 us-gaap Sales Revenue Services Gross
SalesRevenueServicesGross
1187807
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2057540
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2052059
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5592
CY2013Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
42806
CY2013Q2 us-gaap Licenses Revenue
LicensesRevenue
2694220
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2057651
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-2052059
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5481
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
5939678
CY2013Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
37214
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2032316
CY2013Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1461897
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1976020
CY2013Q2 us-gaap Other Cost Of Services
OtherCostOfServices
229392
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
685633
CY2013Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2013Q2 us-gaap Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net
OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet
0
CY2013Q2 us-gaap License Costs
LicenseCosts
240053

Files In Submission

Name View Source Status
0001193125-13-321455-index-headers.html Edgar Link pending
0001193125-13-321455-index.html Edgar Link pending
0001193125-13-321455.txt Edgar Link pending
0001193125-13-321455-xbrl.zip Edgar Link pending
d551018d10q.htm Edgar Link pending
d551018dex311.htm Edgar Link pending
d551018dex312.htm Edgar Link pending
d551018dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
mitk-20130630.xml Edgar Link completed
mitk-20130630.xsd Edgar Link pending
mitk-20130630_cal.xml Edgar Link unprocessable
mitk-20130630_def.xml Edgar Link unprocessable
mitk-20130630_lab.xml Edgar Link unprocessable
mitk-20130630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending